DA Davidson analyst Linda Bolton Weiser raised the firm’s price target on Nu Skin to $40 from $34 and keeps a Neutral rating on the shares. Bolton Weiser came away from recent meetings with Nu Skin remaining on the sidelines, and the analyst is concerned that the firm’s Q1 EPS estimate of 56c is so much below consensus of 71c, she tells investors in a research note. She also thinks consensus operating profit growth of 14% in 2023E is too high, as only half the $100M of restructuring cost savings will be incremental in 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NUS: